ATON Announces the full redemption of the ORAs subscribed par IRIS Capital

Illkirch, 24 August 2026 - Aton Group, a specialist in life sciences and medical technologies, announces that, as of today, it has fully redeemed the outstanding redeemable bonds in shares (ORAs) issued under its financing facility subscribed by Iris Capital and established in 2021.

This facility has been one of the pillars of the Group's financing over recent years, enabling it to raise approximately €11 million out of a maximum contractual capacity of €50 million, supporting the Group's restructuring, development and the acceleration of its expansion, particularly in diagnostic technologies.

Download ATON Press Release (in French)